Annual Cash & Cash Equivalents
$19.16 M
+$12.64 M+193.76%
December 31, 2021
Summary
- As of February 23, 2025, VIVE annual cash & cash equivalents is $19.16 million, with the most recent change of +$12.64 million (+193.76%) on December 31, 2021.
- During the last 3 years, VIVE annual cash & cash equivalents has fallen by -$10.36 million (-35.09%).
- VIVE annual cash & cash equivalents is now -35.09% below its all-time high of $29.52 million, reached on December 31, 2018.
Performance
VIVE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$5.91 M
-$3.52 M-37.37%
September 30, 2022
Summary
- As of February 23, 2025, VIVE quarterly cash and cash equivalents is $5.91 million, with the most recent change of -$3.52 million (-37.37%) on September 30, 2022.
- Over the past year, VIVE quarterly cash and cash equivalents has stayed the same.
- VIVE quarterly cash and cash equivalents is now -84.61% below its all-time high of $38.38 million, reached on March 31, 2018.
Performance
VIVE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VIVE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +193.8% | 0.0% |
| 3 y3 years | -35.1% | 0.0% |
| 5 y5 years | -7.6% | 0.0% |
VIVE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -69.2% | at low |
| 5 y | 5-year | at high | +193.8% | -79.2% | at low |
| alltime | all time | -35.1% | +7327.1% | -84.6% | +6689.7% |
Viveve Medical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.91 M(-37.4%) |
| Jun 2022 | - | $9.43 M(-32.9%) |
| Mar 2022 | - | $14.04 M(-26.7%) |
| Dec 2021 | $19.16 M(+193.8%) | $19.16 M(-15.5%) |
| Sep 2021 | - | $22.66 M(-10.7%) |
| Jun 2021 | - | $25.39 M(-10.7%) |
| Mar 2021 | - | $28.45 M(+336.1%) |
| Dec 2020 | $6.52 M(-51.0%) | $6.52 M(-29.1%) |
| Sep 2020 | - | $9.20 M(+8.2%) |
| Jun 2020 | - | $8.50 M(-6.0%) |
| Mar 2020 | - | $9.04 M(-32.1%) |
| Dec 2019 | $13.31 M(-54.9%) | $13.31 M(+46.5%) |
| Sep 2019 | - | $9.09 M(-4.4%) |
| Jun 2019 | - | $9.51 M(-46.7%) |
| Mar 2019 | - | $17.82 M(-39.6%) |
| Dec 2018 | $29.52 M(+42.4%) | $29.52 M(+46.9%) |
| Sep 2018 | - | $20.10 M(-33.5%) |
| Jun 2018 | - | $30.21 M(-21.3%) |
| Mar 2018 | - | $38.38 M(+85.1%) |
| Dec 2017 | $20.73 M(+156.4%) | $20.73 M(+7.9%) |
| Sep 2017 | - | $19.21 M(-38.2%) |
| Jun 2017 | - | $31.06 M(-1.0%) |
| Mar 2017 | - | $31.39 M(+288.2%) |
| Dec 2016 | $8.09 M(+9.9%) | $8.09 M(-42.3%) |
| Sep 2016 | - | $14.01 M(-29.7%) |
| Jun 2016 | - | $19.93 M(+298.1%) |
| Mar 2016 | - | $5.01 M(-32.0%) |
| Dec 2015 | $7.36 M(+722.3%) | $7.36 M(+21.4%) |
| Sep 2015 | - | $6.06 M(-27.5%) |
| Jun 2015 | - | $8.36 M(+3683.7%) |
| Mar 2015 | - | $221.00 K(-75.3%) |
| Dec 2014 | $895.00 K(+16.4%) | $895.00 K(-54.7%) |
| Sep 2014 | - | $1.98 M(+2172.4%) |
| Jun 2014 | - | $87.00 K(-32.0%) |
| Mar 2014 | - | $128.00 K(-83.4%) |
| Dec 2013 | $769.00 K(+198.1%) | $769.00 K(-45.2%) |
| Sep 2013 | - | $1.40 M(+24.5%) |
| Jun 2013 | - | $1.13 M(-39.5%) |
| Mar 2013 | - | $1.86 M(+622.1%) |
| Dec 2012 | $258.00 K(-90.0%) | $258.00 K(-64.3%) |
| Sep 2012 | - | $723.00 K(-27.5%) |
| Jun 2012 | - | $997.00 K(-37.7%) |
| Mar 2012 | - | $1.60 M(-38.1%) |
| Dec 2011 | $2.58 M(+95.2%) | $2.58 M(-18.6%) |
| Sep 2011 | - | $3.17 M(-21.8%) |
| Jun 2011 | - | $4.06 M(-22.8%) |
| Mar 2011 | - | $5.26 M(+297.1%) |
| Dec 2010 | $1.32 M(-50.7%) | $1.32 M(-0.1%) |
| Sep 2010 | - | $1.32 M(-10.1%) |
| Jun 2010 | - | $1.47 M(-20.0%) |
| Mar 2010 | - | $1.84 M(-31.4%) |
| Dec 2009 | $2.69 M(-46.6%) | $2.69 M(-17.4%) |
| Sep 2009 | - | $3.25 M(-8.4%) |
| Jun 2009 | - | $3.55 M(-17.8%) |
| Mar 2009 | - | $4.32 M(-14.1%) |
| Dec 2008 | $5.03 M(-37.6%) | $5.03 M(-9.2%) |
| Sep 2008 | - | $5.54 M(+0.6%) |
| Jun 2008 | - | $5.51 M(-19.5%) |
| Mar 2008 | - | $6.84 M(-15.1%) |
| Dec 2007 | $8.06 M | $8.06 M(-7.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2007 | - | $8.71 M(+0.8%) |
| Jun 2007 | - | $8.64 M(-14.2%) |
| Mar 2007 | - | $10.08 M(+67.0%) |
| Dec 2006 | $6.03 M(+135.7%) | $6.03 M(+27.2%) |
| Sep 2006 | - | $4.74 M(-3.1%) |
| Jun 2006 | - | $4.90 M(-2.7%) |
| Mar 2006 | - | $5.03 M(+96.6%) |
| Dec 2005 | $2.56 M(-73.5%) | $2.56 M(-9.1%) |
| Sep 2005 | - | $2.82 M(+6.5%) |
| Jun 2005 | - | $2.65 M(+1.8%) |
| Mar 2005 | - | $2.60 M(-73.1%) |
| Dec 2004 | $9.68 M(+51.8%) | $9.68 M(-6.1%) |
| Sep 2004 | - | $10.31 M(+0.6%) |
| Jun 2004 | - | $10.25 M(-5.8%) |
| Mar 2004 | - | $10.88 M(+70.6%) |
| Dec 2003 | $6.38 M(+7.5%) | $6.38 M(+2.6%) |
| Sep 2003 | - | $6.22 M(+5.5%) |
| Jun 2003 | - | $5.89 M(+8.3%) |
| Mar 2003 | - | $5.44 M(-8.3%) |
| Dec 2002 | $5.93 M(+19.2%) | $5.93 M(+8.6%) |
| Sep 2002 | - | $5.46 M(+2.2%) |
| Jun 2002 | - | $5.34 M(+2.8%) |
| Mar 2002 | - | $5.19 M(+4.4%) |
| Dec 2001 | $4.98 M(-13.1%) | $4.98 M(-8.6%) |
| Sep 2001 | - | $5.44 M(-9.6%) |
| Jun 2001 | - | $6.02 M(-16.9%) |
| Mar 2001 | - | $7.25 M(+26.6%) |
| Dec 2000 | $5.73 M(+28.2%) | $5.73 M(-17.9%) |
| Sep 2000 | - | $6.98 M(-6.1%) |
| Jun 2000 | - | $7.43 M(-8.1%) |
| Mar 2000 | - | $8.09 M(+81.0%) |
| Dec 1999 | $4.47 M(-6.9%) | $4.47 M(-20.2%) |
| Sep 1999 | - | $5.60 M(+40.0%) |
| Jun 1999 | - | $4.00 M(-16.7%) |
| Mar 1999 | - | $4.80 M(0.0%) |
| Dec 1998 | $4.80 M(+37.1%) | $4.80 M(-42.2%) |
| Sep 1998 | - | $8.30 M(-28.4%) |
| Jun 1998 | - | $11.60 M(+16.0%) |
| Mar 1998 | - | $10.00 M(+185.7%) |
| Dec 1997 | $3.50 M(+16.7%) | $3.50 M(-16.7%) |
| Sep 1997 | - | $4.20 M(+147.1%) |
| Jun 1997 | - | $1.70 M(-63.8%) |
| Mar 1997 | - | $4.70 M(+56.7%) |
| Dec 1996 | $3.00 M(+328.6%) | $3.00 M(-28.6%) |
| Sep 1996 | - | $4.20 M(-2.3%) |
| Jun 1996 | - | $4.30 M(+2.4%) |
| Mar 1996 | - | $4.20 M(+500.0%) |
| Dec 1995 | $700.00 K(-81.1%) | $700.00 K(-81.1%) |
| Dec 1994 | $3.70 M(-17.8%) | $3.70 M(-67.8%) |
| Sep 1994 | - | $11.50 M(+187.5%) |
| Jun 1994 | - | $4.00 M(-4.8%) |
| Mar 1994 | - | $4.20 M(-6.7%) |
| Dec 1993 | $4.50 M(+21.6%) | $4.50 M(-10.0%) |
| Sep 1993 | - | $5.00 M(-12.3%) |
| Jun 1993 | - | $5.70 M(+83.9%) |
| Mar 1993 | - | $3.10 M(-16.2%) |
| Dec 1992 | $3.70 M(+85.0%) | $3.70 M(-17.8%) |
| Sep 1992 | - | $4.50 M(+1025.0%) |
| Jun 1992 | - | $400.00 K(-71.4%) |
| Mar 1992 | - | $1.40 M(-30.0%) |
| Dec 1991 | $2.00 M | $2.00 M |
FAQ
- What is Viveve Medical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Viveve Medical?
- What is Viveve Medical annual cash & cash equivalents year-on-year change?
- What is Viveve Medical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Viveve Medical?
- What is Viveve Medical quarterly cash and cash equivalents year-on-year change?
What is Viveve Medical annual cash & cash equivalents?
The current annual cash & cash equivalents of VIVE is $19.16 M
What is the all time high annual cash & cash equivalents for Viveve Medical?
Viveve Medical all-time high annual cash & cash equivalents is $29.52 M
What is Viveve Medical annual cash & cash equivalents year-on-year change?
Over the past year, VIVE annual cash & cash equivalents has changed by +$12.64 M (+193.76%)
What is Viveve Medical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VIVE is $5.91 M
What is the all time high quarterly cash and cash equivalents for Viveve Medical?
Viveve Medical all-time high quarterly cash and cash equivalents is $38.38 M
What is Viveve Medical quarterly cash and cash equivalents year-on-year change?
Over the past year, VIVE quarterly cash and cash equivalents has changed by $0.00 (0.00%)